Conditions: Various Advanced Cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 270
Healthy volunteers: no

Brief summary:
The purpose the study is to measure the effect of nivolumab (BMS-936558) in reducing tumor size in subjects with metastatic or unresectable bladder cancer.

Detailed description:

Arms:
arm 1: Nivolumab intravenous infusion as specified

Interventions: intervention 1: Nivolumab
Intervention descriptions: intervention 1: None

Protocol document: